These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

210 related items for PubMed ID: 6795260

  • 1. Antibody-independent interactions between Escherichia coli J5 and human complement components.
    Betz SJ, Isliker H.
    J Immunol; 1981 Nov; 127(5):1748-54. PubMed ID: 6795260
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Antibody-independent activation of C1. II. Evidence for two classes of nonimmune activators of the classical pathway of complement.
    Peitsch MC, Kovacsovics TJ, Tschopp J, Isliker H.
    J Immunol; 1987 Mar 15; 138(6):1871-6. PubMed ID: 3029223
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Interaction of fluid phase C1/C1q and macrophage membrane-associated C1q with gram-negative bacteria.
    Clas F, Euteneuer B, Stemmer F, Loos M.
    Behring Inst Mitt; 1989 Jul 15; (84):236-54. PubMed ID: 2552981
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Inhibition of the hemolytic activity of the first component of complement C1 by an Escherichia coli C1q binding protein.
    van den Berg RH, Faber-Krol MC, van de Klundert JA, van Es LA, Daha MR.
    J Immunol; 1996 Jun 01; 156(11):4466-73. PubMed ID: 8666822
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Activation of the first component of complement, C1, by a monoclonal antibody recognizing the C chain of C1q.
    Heinz HP, Burger R, Golan MD, Loos M.
    J Immunol; 1984 Feb 01; 132(2):804-8. PubMed ID: 6606678
    [Abstract] [Full Text] [Related]

  • 15. Characterization of C1q by monoclonal antibodies.
    Heinz HP, Loos M.
    Behring Inst Mitt; 1984 Nov 01; (76):42-58. PubMed ID: 6335397
    [Abstract] [Full Text] [Related]

  • 16. Activation of C1 by soluble IgG aggregates as detected by a novel one-step hemolytic assay that specifically measures the proenzyme form of C1s.
    Doekes G, van Es LA, Daha MR.
    J Immunol; 1983 Oct 01; 131(4):1924-9. PubMed ID: 6604753
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Complement activating property of the protein-rich endotoxin (OEP) of Pseudomonas aeruginosa. I. Activation of both the classical and the alternative pathways of guinea pig complement.
    Inada K.
    Jpn J Exp Med; 1980 Feb 01; 50(1):13-21. PubMed ID: 6770130
    [Abstract] [Full Text] [Related]

  • 19. Neutralization of vesicular stomatitis virus (VSV) by human complement requires a natural IgM antibody present in human serum.
    Beebe DP, Cooper NR.
    J Immunol; 1981 Apr 01; 126(4):1562-8. PubMed ID: 6259260
    [Abstract] [Full Text] [Related]

  • 20. Surface-bound capsular polysaccharide of type Ia group B Streptococcus mediates C1 binding and activation of the classic complement pathway.
    Levy NJ, Kasper DL.
    J Immunol; 1986 Jun 01; 136(11):4157-62. PubMed ID: 3517165
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.